Description
This product utilizes NK cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO21). We employs the pAS (pBAD-mCherry-TFIIA-EcoRI) vector components and the SynExpress system of the exons Deletion/Adaptive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO21
Species Reactivity
Human
Cell Source
NK cells
Sensor Gene
mCherry
Promoter
pBAD
Effector Gene
TFIIA
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
pAS
Transformation Accuracy
0.98
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.